Ceredex Value Advisors LLC Takes $24.86 Million Position in Agilent Technologies, Inc. $A

Ceredex Value Advisors LLC bought a new position in Agilent Technologies, Inc. (NYSE:A) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 187,150 shares of the medical research company’s stock, valued at approximately $24,859,000. Ceredex Value Advisors LLC owned approximately 0.07% of Agilent Technologies at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in A. Mystic Asset Management Inc. purchased a new position in Agilent Technologies during the 2nd quarter valued at approximately $324,000. Advisors Capital Management LLC purchased a new position in shares of Agilent Technologies in the second quarter valued at $8,299,000. Vise Technologies Inc. purchased a new stake in Agilent Technologies during the second quarter valued at $1,304,000. OVERSEA CHINESE BANKING Corp Ltd bought a new position in Agilent Technologies during the second quarter valued at $3,524,000. Finally, E Fund Management Co. Ltd. bought a new position in Agilent Technologies during the second quarter valued at $440,000.

Agilent Technologies Stock Up 0.7%

Shares of NYSE A opened at $156.50 on Friday. Agilent Technologies, Inc. has a 1 year low of $108.35 and a 1 year high of $160.27. The firm has a 50-day simple moving average of $136.98 and a two-hundred day simple moving average of $126.00. The company has a market cap of $44.20 billion, a P/E ratio of 31.43, a PEG ratio of 2.75 and a beta of 1.25. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.10 and a quick ratio of 1.62.

Agilent Technologies (NYSE:A) last released its earnings results on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, beating analysts’ consensus estimates of $1.41 by $0.08. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The firm had revenue of $1.83 billion for the quarter, compared to analysts’ expectations of $1.80 billion. During the same quarter in the prior year, the firm posted $1.31 earnings per share. The company’s quarterly revenue was up 10.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Research analysts anticipate that Agilent Technologies, Inc. will post 6.03 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on the stock. Jefferies Financial Group assumed coverage on shares of Agilent Technologies in a report on Thursday, July 9th. They issued a “hold” rating and a $135.00 target price on the stock. Weiss Ratings upgraded Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research report on Tuesday, June 2nd. Sanford C. Bernstein initiated coverage on Agilent Technologies in a research note on Friday, June 26th. They set an “outperform” rating and a $155.00 price objective on the stock. Wall Street Zen upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Sunday, August 2nd. Finally, HSBC lowered their price objective on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a research note on Wednesday, June 3rd. Two investment analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat.com, Agilent Technologies presently has an average rating of “Moderate Buy” and an average price target of $160.24.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.